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Abstract 
Biosynthesis of the bacterial peptidoglycan cell wall is essential for determining bacterial 
shape and protection from differences in osmolaric pressure. One necessary step for the 
construction of the bacterial cell wall is the translocation of the lipid-linked peptidoglycan 
precursor, Lipid II, across the cytoplasmic membrane. MurJ is the flippase that translocates lipid 
II in Escherichia coli anda target of recently discovered antibacterials. Little is known about the 
mechanism of flippase proteins such as MurJ. However, crystal structures recently have shown 
MurJ in multiple inward- and outward-open conformations. These crystal structures, along with 
structure-guided in vivo cysteine cross-linking data, have suggested an alternating-access 
mechanism of function for MurJ. Since this cross-linking method allows probing of the different 
conformations of MurJ in vivo, here, we utilized this method to examine how changes to residues 
critical to MurJ function affect the conformation of the flippase in vivo. Our data suggest that 
MurJ mutant proteins containing R18E stall or slow down function so they are mostly found in 
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Introduction 
In gram-negative bacteria like Escherichia coli, the cellular envelope contains four main 
components: the inner membrane (IM), the outer membrane (OM), the aqueous compartment 
between them known as the periplasm, and the peptidoglycan layer (PG) (Figure 1) (Silhavy et 
al. 2010). The peptidoglycan layer is an 
essential layer that is also known as the 
cell wall in bacteria. It is a polymeric 
lattice made up of glycan chains of two 
alternating sugars, N-acetylglucosamine 
(NAG) and N-acetylmuramic 
acid (NAM) crosslinked by a β-(1,4)-
glycosidic bond. NAM molecules are 
monosaccharides with five amino acids attached to them. These peptides allow adjacent glycan 
strands to be crosslinked together to form the mesh-like peptidoglycan structure. The 
peptidoglycan layer gives bacteria structural 
support and their shape. It also protects their 
cytoplasmic or inner membrane from hypotonic 
environments that would cause lysis. Given these 
essential functions of the peptidoglycan cell wall 
and the fact that it is unique to bacterial cells, as 
human cells do not synthesize peptidoglycan, 
peptidoglycan biogenesis is a target for many 
antibiotics like the penicillins (Typas et al. 2011, Lovering et al. 2012). 
Figure 1: Bacterial Envelope Overview. OM is the 
outer membrane, PG is the peptidoglycan layer, IM is 
the inner membrane (Figure adapted from Sujeet 
Kumar). 
Figure 2: Synthesis of Lipid II and 
Peptidoglycan (Figure from Butler et al. 
2013). 
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In E. coli, it has been previously shown that a protein called MurJ, located in the inner 
membrane, is essential for peptidoglycan synthesis (Ruiz 
2008, Inoue et al. 2008). MurJ transports lipid II, the 
lipid-linked building block for the peptidoglycan layer, 
across the inner membrane (Figure 2) (Ruiz 2008, Inoue 
et al. 2008, Sham et al. 2014). This transport is a 
necessary step of peptidoglycan synthesis because 
lipid II is synthesized in the inner leaflet on the inner 
membrane but can only be utilized on the outer leaflet 
of the inner membrane. However, the mechanism for 
how MurJ transports this molecule is unknown. MurJ 
is known to be a flippase, but in general, very little is 
understood about the mechanism of flippase proteins 
(Butler et al. 2014).  
MurJ is conserved in bacteria that produce peptidoglycan, so understanding important 
components to its function could be useful in developing new antibiotics that target this protein 
in many pathogens such as (Mohamed et. al 2014, Huber et. al 2009). This is especially of 
interest because antibiotics that would target peptidoglycan synthesis will lessen the potential 
for negatively impacting animal cells, since the peptidoglycan layer is unique to the bacterial 
envelope. 
Figure 3: MurJ Structure. (A) Residue 
R18 is represented as the green spheres, 
R24 as the red spheres, R52 as the blue 
spheres and R270 as orange spheres. (B) 
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MurJ is a V-shaped protein with 14 transmembrane domains (Butler et. al 2013). These 
transmembrane domains can be split into two groups: The amino-terminal (N) lobe, that consists 
of transmembrane domains 1-6, and the carboxyl-terminal (C) lobe, that consists of 
transmembrane domains 7-14. Inside the V-shape these two lobes form, there is a large cationic 
cavity. The cavity is formed by transmembrane domains 1, 2, 7 and 8 (Kuk et al. 2017, Zheng et 
al. 2018, Butler et. al 2013, Butler et. al 2014). Within MurJ’s central cavity, there are eight 
charged residues critical for function. When these residues are changed to other amino acids, 
they cause either a total or a partial loss of MurJ function (Butler et al. 2014). Four notable 
residues that specifically render MurJ nonfunctional when changed to non-positively charged 
residues are R18, R24, R52 and R270 (Figure 3). However, we do not understand the specific 
role these residues play on MurJ function, and this study explores the relationship between these 
four arginine amino acid residues that are essential for function and their effect on the 
conformational state of MurJ.  
Based on recent crystal structure data, it is now 
known that MurJ exists in several structural 
confirmations, including inward closed, inward open, 
inward occluded and outward open (Figure 4). These 
structures suggest an alternating-access mechanism for 
function of MurJ (Kuk et al. 2019).  
Further evidence to support the alternating-
access mechanism for MurJ function was obtained in 
vivo. The proton motive force (PMF) was previously 
found to be necessary for MurJ flippase activity. Specifically, membrane potential is required 
Figure 4: Conformational 
Structures of MurJ (Figure adapted 
from Kuk et al. 2019). 
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for function, and disruption of membrane potential led to a conformational change of MurJ to 
favor an outward-open state, suggesting that it exists in vivo (Rubino et al. 2018). Then, by 
structure-guided in vivo cysteine cross-linking and proteolysis-coupled gel analysis, both an 
inward-open and an outward-open conformation could be probed for and visualized, illustrating 
conformational structures that exist in vivo (Kumar et al. 2019). Using this method, cysteines 
were introduced and crosslinked either the periplasmic or cytoplasmic side of MurJ. In one 
conformation, these cysteines would not come in a cross-linking distance by the crosslinkers 
used. In the other conformation, the cysteines would then come close enough together to be 
crosslinked, thus demonstrating the existence of that conformation. Since results showed that 
MurJ can be in both inward-open and outward-open conformations  in vivo, MurJ is thought to 
function by an alternate-access mechanism (Kumar et al. 2019, Alvin et al. 2019, Rubino et al. 
2018). Therefore, the current model is that Lipid II enters MurJ from the inner leaflet of the 
inner membrane while MurJ is in an inward-open facing state, and then lipid II is flipped across 
the membrane by MurJ, which opens to an outward-facing conformation. Afterwards, by some 
unknown mechanism requiring membrane potential, MurJ flips back to an inward-facing 
conformation (Figure 5). In this work, we test 
whether substitutions in the MurJ cavity that 
render the flippase non-functional lock MurJ 





Figure 5: Current model of MurJ flippase 
function. Two conformations are shown in this 
model, an inward-facing conformation facing 
toward the cytoplasm and an outward-facing 
model opening to the periplasm. (Adapted from 
Kumar et al. 2019) 
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Methods 
Bacterial strains and growth conditions.  
Strains used are listed in Table 1. Cells grew at 37°C with aeration in lysogeny broth (LB) with 
ampicillin (125 μg/ml), and growth was monitored by optical density at 600 nm (OD600).  
Table 1: Strains used in the study 
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NR3267 NR754 ∆murJ::FRT (pRC7KanMurJ) 
(Kumar et 
al. 2019) 
NR 5795  NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin) WT This study 
NR5755  NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/V43C/T251C) 
(Kumar et 
al.  2019) 
NR5757  NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/S73C/A296C) 
(Kumar et 
al. 2019) 
NR5796  NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/R18E/V43C/T251C) This study 
NR5826  NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/R18E/S73C/A296C) This study 
NR5797  NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/R24E/V43C/T251C) This study 
NR5846  NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/R24E/S73C/A296C) This study 
NR5798  NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/R52E/V43C/T251C) This study 
NR 5827 NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/R52E/S73C/A296C) This study 
NR 5809 NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/R270E/V43C/T251C) This study 
NR 5828 NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/R270E/S73C/A296C) This study 
NR 5829 NR754 (pET23/42FLAGMurJ∆Cys-222Thrombin/A29W/V43C/T251C) This study 
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Plasmids construction and site-directed mutagenesis (SDM).  
Primers are listed in Table 2. Plasmids were constructed using Phusion polymerase. 
Construction of pRC7KanMurJ and pET23/42FLAGMurJ∆Cysthrombin was previously 
described (Kumar et al. 2019).  
The pET23/42FLAGMurJ∆Cysthrombin derivatives with glutamate or tryptophan 
substitutions were generated using SDM PCR. Plasmids with double Cys-codon substitutions in 
Flag-murJ∆Cys-thrombin were used as templates to introduce the third mutation, the glutamate 
to arginine mutation or alanine to tryptophan mutation.  
All the substitutions were made by using SDM PCR with Phusion polymerase (95ºC for 
2 min, followed by 19 cycles of 95ºC for 30 s, 60ºC for 30 s, and 72ºC for 14 min and a final 
extension of 72ºC for 12 min) according to the manufacturer’s instructions. The variants made 
in pET23/42FLAGMurJ∆Cys-thrombin were electroporated into DH5α and transformants were 
selected on LB agar containing 125 μg/mL ampicillin.  
Table 2: Primers used in the study 
PRIMER 
NAME 
SEQUENCE 5’-3’ PURPOSE 
5murJR18E CATGTTTTCGGAGGTGCTTGGCTTCGCACGAG SDM 
3murJR18E CCAAGCACCTCCGAAAACATGGTCATCGAGC SDM 
5murJR24E GGCTTCGCAGAGGACGCAATTGTCGCCAGAATCTTTG SDM 
3murJR24E CAATTGCGTCCTCTGCGAAGCCAAGCACACGCG SDM 
5murJR52E CTTGTTAGAGCGTATCTTTGCCGAAG SDM 
3murJR52E CAAAGATACGCTCTAACAAGTTAGGAAGTTTAAAAGCG SDM 
5murJR270E CGCCGACGAGTTAATGGAGTTTCCGTCCGG SDM 
3murJR270E CTCCATTAACTCGTCGGCGTAATACATCCAAG SDM 
5murJA29W CAATTGTCTGGAGAATCTTTGGCGCAGGGATGGC SDM 
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3murJA29W CAAAGATTCTCCAGACAATTGCGTCTCGTGCG SDM 
 
Functionality testing for pET23/42FLAGMurJ∆Cys-thrombin derivatives. 
The ability of pET23/42FLAGMurJ∆Cysthrombin-derived plasmids to functionally 
complement the loss of murJ was evaluated as described previously (Butler et. al 2013, Butler 
et. al 2014, Chamakura et. al 2017) using strain NR3267 (NR754 ∆murJ::frt pRC7KanMurJ) 
(Elhenawy et. al 2016).  
In vivo cysteine cross-linking using a maleimide homobifunctional cross-linker.  
The in vivo cysteine cross-linking procedure used was previous described (Kumar et. al 
2019). Strains were grown to OD600 1 in LB medium containing ampicillin and 10 ml of 
culture was used. Each suspension was treated with either dimethyl sulfoxide (DMSO; solvent 
used for dissolving crosslinkers) or with the homobifunctional maleimide cross-linker N,N′-(o-
phenylene)dimaleimide (oPDM; Sigma) at a final concentration of 1 mM. Samples were 
incubated on a rotator at room temperature for 5 min in the dark during crosslinking treatment, 
then quenched with L-cysteine (Sigma; 10 mM final concentration) for 5 min at room 
temperature on a rotator. For spheroplast formation, the samples were resuspended in 
spheroplast buffer (50 mM Tris-HCl, pH 8.0, 1 M sucrose, 2 mM EDTA) with 0.125 mg/ml 
lysozyme. After incubating at room temperature for 15 min, 40 µl of 1M MgCl2 was added. 
Spheroplast formation was confirmed through microscopy, then collected by centrifugation and 
resuspended in 500 µl of 50 mM Tris-HCl, pH 8.0 containing 1 µl Benzonase (Novagen). 
Spheroplast membranes were pelleted using ultracentrifugation at 100,000 rpm for 1hr at 4ºC in 
a Optima-MAX-TL ultracentrifuge (Beckman Coulter) using TLA120.2 rotor. The membrane 
pellet was resuspended in thrombin reaction buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 
2.5 mM CaCl2, 1% DDM) (Hennon et. al 2014), and samples were centrifuged to remove 
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insolubilized or aggregated proteins. After centrifugation, 0.4 units of thrombin protease 
(Sigma) were added to 50 µl of the solubilized membrane fraction only for treated samples. The 
reaction was next incubated overnight at room temperature. Then, equal volume of 2X AB 
buffer (6.84 mM Na2HPO4, 3.16 mM NaH2PO4, 50 mM Tris-HCl, pH 6.8, 6 M urea, 1% β-
mercaptoethanol, 3% SDS, 10% glycerol, 0.1% bromophenol blue) (Butler et. al 2013, Butler et. 
al 2014) was added to the samples and loaded onto 10% SDS-polyacrylamide gels for 
electrophoresis and detection by immunoblotting. 
Immunoblotting for FLAG-MurJ detection.  
Samples were prepared as explained above for the cysteine cross-linking experiments or 
as follows for biogenesis of FLAGMurJ by immunoblotting since the selected arginine and 
alanine reside mutations are total loss of function mutations of MurJ.  
Cells were grown overnight and normalized by dividing 400 by OD600 values. Then, 
they were pelleted by centrifugation and lysed with 50 µl of BugBuster protein extraction 
reagent (Novagen) and 1 µl of Benzonase (Novagen). After incubating the samples from the 
biogenesis or cross-linking procedures at room temperature, 50 µl of 2XAB buffer was added. 
Samples were loaded onto a 10% SDS-polyacrylamide gel for electrophoresis. Proteins 
were then transferred from the gel to a polyvinylidene difluoride (PVDF) membrane at 10V for 
2 h using semi-dry transfer apparatus (BioRad). PVDF membranes were probed with anti-FLAG 
M2 (1:10,000; SigmaAldrich) and anti-mouse horseradish peroxidase (HRP; 1:10,000; GE 
Amersham) antibodies. Signals were developed using the Clarity Western ECL substrate as per 
the manufacturer’s instructions (Bio-Rad) and detected using a ChemiDoc XRS+ system (Bio-
Rad). 
 




We wanted to use site-directed cysteine in vivo cross-linking to test if non-functional 
mutations that change specific essential arginine or alanine residues stalled MurJ in one 
conformation, either a conformation that was open to the cytoplasm (i.e. inward open) or one 
open to the periplasm (i.e. outward open) (Butler et. al 2013, Butler et. al 2014). Several 
charged residues in MurJ’s central cavity are critical for its function, including residues R18, 
R24, R52, and R270 (Butler et. al 2014). We hypothesized that substitutions at these sites cause 
MurJ to be stalled in one conformation, thus halting MurJ’s function. Another residue examined 
was A29. Residue A29 is at the interface of the N-lobe and C-lobe in the periplasmic side of 
MurJ. We know that the MurJA29C variant is functional. However, when MurJA29C was treated 
with sodium (2-sulfonatoethyl) methanethiosulfonate (MTSES), which covalently binds to 
cysteines, it became nonfunctional. We hypothesized that the addition of MTSES to position 
A29C adds bulkiness that prevents MurJ from being able to adopt an inward-open conformation, 
causing MurJ to be stuck in the outward-open state and making it nonfunctional. 
For this strategy, we introduced paired cysteine residues into each of the lobes of MurJ 
and used a homobifunctional cross-linking reagent that could cross-link specific cysteine pairs 
when the two lobes adopted only one of the two conformations, as described previously (Kumar 
et. al 2019). All variants were encoded in pET23/42FLAGMurJ∆Cys-thrombin plasmids.  
Construction of loss-of-function variants. 
In order to test the function of the murJ alleles encoding the desired MurJ variants, we 
used strain NR3267, which carries the pCR7KanMurJ plasmid (Elhenawy 2017). The 
pRC7KanMurJ plasmid has two important features that allow us to screen for functionality of 
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murJ alleles on different plasmids. First, pRC7KanMurJ has a partitioning defect, so it does not 
equally segregate into daughter cells during cellular division. Because of this defect, the plasmid 
is lost from a population of cells in the absence of selection. This selection can either be the 
absence of a functional murJ allele in the cell from another introduced plasmid, as NR3267 is 
chromosomally ∆murJ, or from selection by kanamycin present in the media. Secondly, 
pRC7KanMurJ encodes β-galactosidase. This allows us to use blue/white screening of colonies 
in the presence of X-gal and IPTG to determine the loss of pRC7KanMurJ from the population. 
Taking advantage of these features of pRC7KanMurJ, we transformed strain NR3267 
with mutagenized pET23/42FLAGMurJ∆Cys-thrombin plasmids. Since all of the mutations we 
generated are known to cause a total loss-of-function phenotype, there was no loss of 
pRC7KanMurJ in cells. Therefore, cells encoding non-functional pET23/42FLAGMurJ∆Cys-
thrombin glutamate or tryptophan derivatives yielded blue colonies, while cells encoding 
functional or non-mutated pET23/42FLAGMurJ∆Cys-thrombin plasmids yielded white 
colonies. Therefore, the alleles we generated behaved as expected. 
Detection of pET23/42FLAGMurJ∆Cys-thrombin variants. 
 To generate pET23/42FLAGMurJ∆Cys-thrombin variants with glutamate or tryptophan 
substitutions, we used a plasmid containing paired cysteine mutants that had been previously 
described for probing for conformational changes in MurJ (Kumar et. al 2019). The two paired 
cysteine combinations we used were V43C/T251C, the periplasmic pair that would only 
crosslink in the inward-facing conformation, and S73C/A296C, the cytoplasmic pair that would 
only crosslink in the outward-facing conformation. Using SDM, residues R18, R24, R52 and 
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R270 individually were changed to a glutamate 
residue in both plasmids. Residue A29 was 
changed to a tryptophan residue only in the 
pET23/42FLAGMurJ∆Cys-thrombin 
V43C/T251C background.  
 Once mutated, we transformed these 
plasmids into the wild-type strain NR754 
to examine the biogenesis of the 
FLAGMurJ variants. Since the plasmids 
were introduced into NR754, which contains 
chromosomal murJ, the resulting strains were 
viable on LB with ampicillin, since the 
pET23/42FLAGMurJ∆Cys-thrombin plasmid 
contains the ampicillin resistance gene. 
Once transformed, the cells were lysed, 
and cellular proteins extracted for 
immunoblotting using anti-FLAG 
antibodies.  
Variants of FLAGMurJ with R18E, 
R24E and R52E substitutions in the 
V43C/T251C background were detected similarly to the V43C/T251C variant (Figure 6A). 
Variants of FLAGMurJ with R18E, R24E, and R52E in the S73C/T251C background showed 
slightly reduced levels as compared to S73C/A296C (Figure 6B and 6C). The levels of the 
Figure 6. Proteolytic analysis of the FLAG-
MurJ∆Cys-thrombin variants used to probe 
conformational states of MurJ. FLAG 
immunoblotting of samples from merodiploid murJ 
strains producing FLAGMurJ∆Cys-thrombin (∆Cys-
Th) and its variants to determine biogenesis of FLAG-
MurJ. LptB immunoblotting (bottom panel) was used 
as a loading control.  (A) Expression of R18E, R24E 
and R52E in the V43C/T251C background. (B) 
Expression of R18E and R52E in the S73C/T251C 
background. (C) Expression of R24E S73C/A296C, 
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FLAGMurJ variant with R270E in V43C/T251C and S73C/A296C were barely at the limit of 
detection (Figure 6C). Since there was nearly no detection, we decided to not move forward 
with R270E for cross-linking. Introduction of A29W into V43C/T251C also led to no detection; 
because of this, we did not generate the A29W variant in the S73C/A296C variant and did not 
move forward with A29W for cross-linking (Figure 6C). As a loading control for all biogenesis 
blots, we detected the LptB protein with an anti-LptB antiserum. 
Conformations of pET23/42FLAGMurJ∆Cys-thrombin variants. 
 As previous described, the addition of the thrombin protease cut site aids in 
differentiating between cross-linked and uncross-
linked products (Kumar et. al 2019). Briefly, the 
loop connecting the N and C lobes of MurJ contains 
the thrombin protease cut site. It can be cleaved by 
the protease thrombin after cells are treated or not 
with cross-linkers. In the absence of cross-linking, 
thrombin should cleave this construct into two 
fragments: one corresponding to the N lobe and the 
other corresponding to the C lobe. Since the N lobe 
has the FLAG tag, only the N lobe can be detected by 
immunoblotting. However, the two fragments should 
remain covalently linked after protease cleavage if the two lobes were cross-linked prior to 
proteolysis and be visible by immunoblot as a band between 35 and 40 kDa, where native MurJ 
runs (Kumar et. al 2019). Because we used 10% acrylamide gels for the immunoblots, only full-






Figure 7. Crosslinking of cysteine 
variants. A) V43C/T251C, the 
periplasmic paired mutations, exhibit 
some crosslinking. B) S73C/T251C, the 
cytoplasmic paired mutations, illustrate 
some crosslinking. 
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resulting from cleaving uncross-linked variants with thrombin is too small to be detected when 
using 10% acrylamide gels. 
 Two paired cysteine mutations were used for assessing the conformation of the non-
functional variants. The V43C and T251C pair is located in the periplasmic side of MurJ. Thus, 
when these two cysteines were cross-linked by o-PDM, it was indicative of an inward-open 
conformation (Figure 7A). Similarly, the cytoplasmic pair used was S73C and A296C. When 
this pair was cross-linked by o-PDM, MurJ was in an outward-open conformation (Figure 7B).  
The first MurJ variant shown in Figure 
8A carries the R18E/V43C/T251C 
substitution. While levels of V43C/T251C 
are somewhat decreased with respect to 
R18E/V43C/T251C, the 
R18E/V43C/T251C variant showed an 
increase in cross-linking. This increase in 
the amount of MurJ variants in inward-
open conformation suggest that the R18E 
change might somehow interfere with the 
ability of MurJ to attain the outward-open 
conformation.  In contrast, the second variant, R24E/V43C/T251C exhibited less crosslinking 
than V43C/T251C (Figure 8B), suggesting that the R24E change might lead to a decrease in the 
ability of MurJ to be the inward-open conformation. 
 
 
Figure 8. In vivo cysteine cross-linking of 
arginine mutants in 
pET23/42FLAGMurJ∆Cysthrombin 
V43C/T251C background. (A) Cross-linking of 
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Discussion 
 MurJ is essential in E. coli because of its function in peptidoglycan synthesis, where it 
flips lipid II from the inner leaflet of the inner membrane to the outer leaflet using an 
alternating-access mechanism of function (Kumar et. al 2019, Kuk et. al 2019, Sham et. al 
2014). In this study, we investigated residues that are critical for the function of MurJ to 
understand how they might participate in inducing conformational structural changes that MurJ 
must undergo during the transport cycle.  
 The five residues we looked at were R18, R24, R52, R270 and A29, which are located in 
the MurJ cavity (Butler et. al 2013, Butler et. al 2014). As expected, changing these residues 
caused a total loss of MurJ function. It has been proposed that the arginines might interact with 
lipid II (Butler et. al 2014,  Kuk et. al 2017, Kuk et. al 2019). We also knew that when MTSES, 
a bulky chemical that reacts with cysteines, was added to a mutant carrying the A29C, MurJ 
function was inhibited (Sham et. al 2014, Butler et. al 2013, Butler et. al 2014). Therefore, we 
hypothesized that the changes we introduced caused a total loss of function because of the 
charge disruption in the arginine residues or the bulkiness added at residue 29 when substituted 
by a tryptophan.  
 Our cross-linking data show that the FLAGMurJ∆Cys-thrombin R18E/V43C/T251C 
MurJ variant appears to prefer an inward conformation, while the FLAGMurJ∆Cys-thrombin 
R24E/V43C/T251C variant might not. Our hypothesis was that variants with the R18E and 
R24E substitutions would cross-link in an inward-facing conformation more than the outward-
facing conformation because these residues are toward the periplasmic side of MurJ. Residue 
R18 functioned in line with our hypothesis, as it exhibited more cross-linking in an inward-open 
conformation than the control. This means that the R18E change might cause MurJ to flip more 
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slowly to the outward-open conformation, or not flip at all. In contrast, residue R24 did not 
cross-link more in an inward-open conformation. This means R24E might cause MurJ to stall 
longer in the outward-open conformation. 
 Further analysis should be done in Mur variants with the S73C/A296C pair and the R18E 
and R24E substitutions to confirm the aforementioned preferred conformations. For example, if 
we expect that the MurJ variant carrying the R18E change prefers the inward-open conformation, 
then levels of cross-linking reflecting the inward-open conformation should increase, while cross-
linking of the S73C/A296C pair should decrease. If MurJ prefers the outward-open confirmation, 
as seen in residue R24E, then we expect to see less cross-linking in the inward-open cross-linking 
pair as we did, and more in the outward-open cross-linking pair we plan to test. We also plan to 
examine the preferred conformation of R52E in both backgrounds to determine if MurJ with this 
change prefers a specific conformation. To study the impact of residues R270 and A29 on MurJ’s 
conformation, we plan to generate new substitutions at those sites that may compromise function 
without causing a biogenesis defect. Determining which conformation MurJ prefers with these 
total loss-of-function mutations can provide us insight to why changes to these residues cause this 
phenotype. Understanding the importance of these residues might help in generating new 
antibiotics that might target MurJ.  
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